Senior Manager, Corporate Development at Acadia Pharmaceuticals

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiopharmaceuticalIndustries

Requirements

PhD, MD, MD/PhD, or Pharm D with keen scientific acumen and strong interest and/or experience in biotech/pharma
Management consulting background is desirable
Genuine interest in healthcare and patient-focused work
Strong organizational skills, with the ability to prioritize critical workstreams while balancing many projects
Strong project management skills with the ability to manage cross-functional teams in evaluating partnering opportunities
Highly collaborative with the ability to thrive in a fast-paced, dynamic, and entrepreneurial environment
Strong communication skills with the ability to effectively communicate scientific and clinical findings in written and oral formats
Ability to produce high quality outputs of due diligence findings to enable decision-making
Ability to present individual and team recommendations clearly and concisely and foster cross-functional consensus-building
Excellent analytical skills, with the ability to synthesize complex scientific and business information

Responsibilities

Proactively source potential peri-clinical and clinical stage assets using a variety of databases, secondary research sources, by attending partnering conferences, networking, and staying abreast of industry trends and advancements
Identify, evaluate, and prioritize new business opportunities, including partnerships, licensing, collaborations, and M&A
Coordinate team diligence efforts including scientific and clinical reviews and commercial assessments
Support all aspects of transaction execution, including due diligence, financial modeling, valuation analysis, contract negotiations, and post-deal integration planning
Conduct interviews with key opinion leaders as needed to gain insights into new disease areas and new therapies in development
Prepare and deliver presentations, deal proposals, and updates to senior leadership and board-level stakeholders
Participate in strategic projects to support corporate development initiatives
Manage outside consultants as needed to support new opportunity assessments
Work with the R&D team to assess the technical feasibility and fit of potential clinical stage assets with existing product pipeline and company capabilities

Skills

Financial Modeling

Valuation Analysis

Due Diligence

Contract Negotiations

M&A

Licensing

Partnerships

Business Development

KOL Interviews

Strategic Analysis

Presentation Skills

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free